112 research outputs found

    Hack the Gap: Making Your Collections and Instruction Accessible for All

    Get PDF
    Waiting for the squirmy student to settle down before having the class start the search activity? Trying to get that small-group table of students to work together instead of separately? How do you encourage that student who started the activity and is now staring blankly at the screen? All of these students could be the brightest and most creative students you have…but they may be too challenged by the busy web interface, by the level of noise, or by the large number of social interactions in the room to complete the assignment you have given them. Our information literacy instruction can often miss students with special needs, who may find it difficult to follow our instruction and may also find themselves unable to easily interact with our databases and online tools. Theresa Borchert and Virginia Connell from Concordia College, Moorhead will provide practical and logistical advice to help make your collections and your instruction more accessible for students in your classes, helping your students bridge the gap by building life-long learning skills

    Going Paperless: First Year Students, Selfies, and Information Literacy

    Get PDF
    It is an ongoing challenge to find an effective method of library instruction that also engages college freshman. At Concordia College – Moorhead we are fortunate enough to conduct a basic information literacy session with every first-year student, we call it the Library Launch. This fall we made the Library Launch paperless for the purposes of sustainability and student participation. In this presentation we will share our experiences developing content, implementing the selected survey tool, and, finally, assessing whether or not the new format met our learning outcomes

    Water reform for all: a national response to a water emergency

    Get PDF
    Australia’s water reform project is failing to fully deliver for all Australians. With the COVID-19 pandemic, long-accepted approaches are being questioned in many areas of national policy. This also applies to water reform. The Australian bush fires of 2019-20 mean that Australians can no longer ignore the devastating impacts of natural disasters in a dryer and warmer country. The new normal is that it will continue to get hotter and, where most Australians live, it will get drier. Rainfall will become more unpredictable and extreme weather events, such as cyclones, more intense. These conditions will make it even more difficult for water managers who, during repeated and prolonged droughts, are struggling to manage the intensification of Australia’s ‘boom and bust’ water availability. To cope with Australia’s water emergency, we need to extract less water and ensure our rivers, lakes and wetlands have the water they need at the right time to deliver ecosystem functions and services: water supply for people and livestock; habitat for plants and animals; water quality and flood regulation; nutrient cycling; recreation; and, importantly, access and use of water by all Australians. Here, we propose six principles to provide a foundation for Water Reform For All: (1) establish shared visions and goals that are community-based and co-produced; (2) develop clarity of roles and responsibilities, including an ability and willingness to revise adaptation plans, actions and visions; (3) understand adaptation as a means to respond to persistent escalation of stresses, including drought, climate change, bush fires and governance failures; (4) invest in advanced technology to monitor, predict and understand changes in water availability in a transforming Australian landscape and grow our shared knowledge as a basis for adaptive water reform; (5) integrate bottom-up community-based adaptation, including from Indigenous communities, into renewed arrangements for water governance; and (6) implement management actions as experiments for ‘learning to do things differently’. These six water reform principles require national conversations, supported by our collective capacity to imagine alternative futures and apply this to decision-making, along with recognition and inclusion of First Peoples’ values and knowledge of land, water and fire. Without national conversations on water reform and deliberative processes, we expect that Australia’s water emergency will continue and, with climate change, get worse. This is a future that we can, and must, change for the benefit of all Australians.The Australian National Universit

    Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition

    Get PDF
    Genomic instability can initiate cancer, augment progression, and influence the overall prognosis of the affected patient. Genomic instability arises from many different pathways, such as telomere damage, centrosome amplification, epigenetic modifications, and DNA damage from endogenous and exogenous sources, and can be perpetuating, or limiting, through the induction of mutations or aneuploidy, both enabling and catastrophic. Many cancer treatments induce DNA damage to impair cell division on a global scale but it is accepted that personalized treatments, those that are tailored to the particular patient and type of cancer, must also be developed. In this review, we detail the mechanisms from which genomic instability arises and can lead to cancer, as well as treatments and measures that prevent genomic instability or take advantage of the cellular defects caused by genomic instability. In particular, we identify and discuss five priority targets against genomic instability: (1) prevention of DNA damage; (2) enhancement of DNA repair; (3) targeting deficient DNA repair; (4) impairing centrosome clustering; and, (5) inhibition of telomerase activity. Moreover, we highlight vitamin D and B, selenium, carotenoids, PARP inhibitors, resveratrol, and isothiocyanates as priority approaches against genomic instability. The prioritized target sites and approaches were cross validated to identify potential synergistic effects on a number of important areas of cancer biology

    PenQuest Volume 1, Number 2

    Get PDF
    Table of Contents for this Volume: Untitled by Julie Ambrose Night by Judith Gallo Untitled by Judy Gozdur the shamans by Charles Riddles Untitled by Jerry Connell Untitled by Laura Woods Untitled by LEMA Wicked Bird by Laura Jo Last Untitled by Rick Dentos Untitled by Jeni Moody Untitled by Bettie W. Kwibs Untitled by Joann Stagg The Protector Stood by Laura Jo Last Visions of Salome by Charles Riddles Untitled by Thomas Tutten Kennesaw Line by Don Ova-Dunaway Stone Blood by Mary Ellen C. Wofford Untitled by Roger Whitt Jr. Untitled by C. Wingate Untitled by Doug Dorey Untitled by Karen Blumberg Untitled by Beverly Oviatt Untitled by Virginia Shrader The Crapulous Credo of Charles C. by Charles Riddles the brave and the true by David Reed Untitled by Charles Gutierrez Canoe Creek by Patricia Kraft Untitled by Linda Bobinger The Man in the Iron Lung by Patricia Kraft Untitled by Roger Whitt, Jr. Childish Things by Kathleen Gay Untitled by Joseph Avanzini The Lover by Mary S. Aken Untitled by Ann Harrington And He Taketh Away by David Reed Untitled by Mary Graham Untitled by Melody A. Cummons Untitled by Karen Blumberg To The Poets by Judith Gallo Untitled by Ann Harringto

    Lipid Metabolites Enhance Secretion Acting on SNARE Microdomains and Altering the Extent and Kinetics of Single Release Events in Bovine Adrenal Chromaffin Cells

    Get PDF
    Lipid molecules such as arachidonic acid (AA) and sphingolipid metabolites have been implicated in modulation of neuronal and endocrine secretion. Here we compare the effects of these lipids on secretion from cultured bovine chromaffin cells. First, we demonstrate that exogenous sphingosine and AA interact with the secretory apparatus as confirmed by FRET experiments. Examination of plasma membrane SNARE microdomains and chromaffin granule dynamics using total internal reflection fluorescent microscopy (TIRFM) suggests that sphingosine production promotes granule tethering while arachidonic acid promotes full docking. Our analysis of single granule release kinetics by amperometry demonstrated that both sphingomyelinase and AA treatments enhanced drastically the amount of catecholamines released per individual event by either altering the onset phase of or by prolonging the off phase of single granule catecholamine release kinetics. Together these results demonstrate that the kinetics and extent of the exocytotic fusion pore formation can be modulated by specific signalling lipids through related functional mechanisms

    multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

    Get PDF
    Funding Information: This project received funding from the European Centre for Disease Prevention and Control (ECDC) under the contract ECD.11486. Funding Information: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673. Publisher Copyright: © 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.Introduction: In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. Methods: Individuals with COVID-19 or acute respiratory symptoms at primary care/community level in 10 European countries were tested for SARS-CoV-2. We measured complete primary course overall VE by vaccine brand and by time since vaccination. Results: Overall VE was 74% (95% CI: 69-79), 76% (95% CI: 71-80), 63% (95% CI: 48-75) and 63% (95% CI: 16-83) among those aged 30-44, 45-59, 60-74 and ≥ 75 years, respectively. VE among those aged 30-59 years was 78% (95% CI: 75-81), 66% (95% CI: 58-73), 91% (95% CI: 87-94) and 52% (95% CI: 40-61), for Comirnaty, Vaxzevria, Spikevax and COVID-19 Vaccine Janssen, respectively. VE among people 60 years and older was 67% (95% CI: 52-77), 65% (95% CI: 48-76) and 83% (95% CI: 64-92) for Comirnaty, Vaxzevria and Spikevax, respectively. Comirnaty VE among those aged 30-59 years was 87% (95% CI: 83-89) at 14-29 days and 65% (95% CI: 56-71%) at ≥ 90 days between vaccination and onset of symptoms. Conclusions: VE against symptomatic infection with the SARS-CoV-2 Delta variant varied among brands, ranging from 52% to 91%. While some waning of the vaccine effect may be present (sample size limited this analysis to only Comirnaty), protection was 65% at 90 days or more between vaccination and onset.publishersversionpublishe

    Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

    Get PDF
    I-MOVE-COVID-19 primary care study team (in addition to authors above): Nick Andrews, Jamie Lopez Bernal, Heather Whitaker, Caroline Guerrisi, Titouan Launay, Shirley Masse, Sylvie van der Werf, Vincent Enouf, John Cuddihy, Adele McKenna, Michael Joyce, Cillian de Gascun, Joanne Moran, Ana Miqueleiz, Ana Navascués, Camino Trobajo-Sanmartín, Carmen Ezpeleta, Paula López Moreno, Javier Gorricho, Eva Ardanaz, Fernando Baigorria, Aurelio Barricarte, Enrique de la Cruz, Nerea Egüés, Manuel García Cenoz, Marcela Guevara, Conchi Moreno-Iribas, Carmen Sayón, Verónica Gomez, Baltazar Nunes, Rita Roquete, Adriana Silva, Aryse Melo, Inês Costa, Nuno Verdasca, Patrícia Conde, Diogo FP Marques, Anna Molesworth, Leanne Quinn, Miranda Leyton, Selin Campbell, Janine Thoulass, Jim McMenamin, Ana Martínez Mateo, Luca Basile, Daniel Castrillejo, Carmen Quiñones Rubio, Concepción Delgado-Sanz, Jesús Oliva.The I-MOVE-COVID-19 network collates epidemiological and clinical information on patients with coronavirus disease (COVID-19), including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virological characterisation in 11 European countries [1]. One component of I-MOVE-COVID-19 is the multicentre vaccine effectiveness (VE) study at primary care/outpatient level in nine European study sites in eight countries. We measured overall and product-specific COVID-19 VE against symptomatic SARS-CoV-2 infection among those aged 65 years and older. We also measured VE by time since vaccination.This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673.info:eu-repo/semantics/publishedVersio
    corecore